Cargando…

Gut Microbiome and Mycobiome Alterations in an In Vivo Model of Alzheimer’s Disease

Gut microbiota has emerged as an important key regulator of health and disease status. Indeed, gut microbial dysbiosis has been identified in an increasing number of diseases, including neurodegenerative disorders. Accordingly, microbial alterations have been reported also in Alzheimer’s disease (AD...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Argenio, Valeria, Veneruso, Iolanda, Gong, Chunmei, Cecarini, Valentina, Bonfili, Laura, Eleuteri, Anna Maria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9498768/ https://www.ncbi.nlm.nih.gov/pubmed/36140732 http://dx.doi.org/10.3390/genes13091564

Ejemplares similares

Modulation of Gut Microbiota and Neuroprotective Effect of a Yeast-Enriched Beer
por: Cecarini, Valentina, et al.
Publicado: (2022)

Endosomal trafficking and related genetic underpinnings as a hub in Alzheimer's disease
por: Limone, Adriana, et al.
Publicado: (2022)

Metagenomics Reveals Specific Microbial Features in Males with Semen Alterations
por: Veneruso, Iolanda, et al.
Publicado: (2023)

Immortalized Alzheimer’s Disease Astrocytes: Characterization of Their Proteolytic Systems
por: Gong, Chunmei, et al.
Publicado: (2023)

Microbiota and Human Reproduction: The Case of Male Infertility
por: Tomaiuolo, Rossella, et al.
Publicado: (2020)

Microbiota and Human Reproduction: The Case of Female Infertility
por: Tomaiuolo, Rossella, et al.
Publicado: (2020)

Microbiota modulation counteracts Alzheimer’s disease progression influencing neuronal proteolysis and gut hormones plasma levels
por: Bonfili, Laura, et al.
Publicado: (2017)

Current Updates on Expanded Carrier Screening: New Insights in the Omics Era
por: Veneruso, Iolanda, et al.
Publicado: (2022)

Strategic Modification of Gut Microbiota through Oral Bacteriotherapy Influences Hypoxia Inducible Factor-1α: Therapeutic Implication in Alzheimer’s Disease
por: Bonfili, Laura, et al.
Publicado: (2021)

Microbiome Influence in the Pathogenesis of Prion and Alzheimer’s Diseases
por: D’Argenio, Valeria, et al.
Publicado: (2019)

Flavan‐3‐ol Microbial Metabolites Modulate Proteolysis in Neuronal Cells Reducing Amyloid‐beta (1‐42) Levels
por: Cecarini, Valentina, et al.
Publicado: (2021)

Targeting Proteolysis with Cyanogenic Glycoside Amygdalin Induces Apoptosis in Breast Cancer Cells
por: Cecarini, Valentina, et al.
Publicado: (2022)

Structure/activity virtual screening and in vitro testing of small molecule inhibitors of 8-hydroxy-5-deazaflavin:NADPH oxidoreductase from gut methanogenic bacteria
por: Cuccioloni, Massimiliano, et al.
Publicado: (2020)

Alterations of the gut mycobiome in patients with MS
por: Shah, Saumya, et al.
Publicado: (2021)

Human Microbiome Acquisition and Bioinformatic Challenges in Metagenomic Studies
por: D’Argenio, Valeria
Publicado: (2018)

The Prenatal Microbiome: A New Player for Human Health
por: D’Argenio, Valeria
Publicado: (2018)

SLAB51 Probiotic Formulation Activates SIRT1 Pathway Promoting Antioxidant and Neuroprotective Effects in an AD Mouse Model
por: Bonfili, Laura, et al.
Publicado: (2018)

Combined aCGH and Exome Sequencing Analysis Improves Autism Spectrum Disorders Diagnosis: A Case Report
por: Ranieri, Annaluisa, et al.
Publicado: (2022)

Comparative Metagenomic Analysis of Human Gut Microbiome Composition Using Two Different Bioinformatic Pipelines
por: D'Argenio, Valeria, et al.
Publicado: (2014)

An Altered Gut Microbiome Profile in a Child Affected by Crohn's Disease Normalized After Nutritional Therapy
por: D'Argenio, Valeria, et al.
Publicado: (2013)

Enhancing the Amyloid-β Anti-Aggregation Properties of Curcumin via Arene-Ruthenium(II) Derivatization
por: Cuccioloni, Massimiliano, et al.
Publicado: (2022)

The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice
por: Cossiga, Valentina, et al.
Publicado: (2021)

The gut mycobiome of the Human Microbiome Project healthy cohort
por: Nash, Andrea K., et al.
Publicado: (2017)

Probiotics, prebiotics and their role in Alzheimer’s disease
por: D'Argenio, Valeria, et al.
Publicado: (2021)

Interfering with the high-affinity interaction between wheat amylase trypsin inhibitor CM3 and toll-like receptor 4: in silico and biosensor-based studies
por: Cuccioloni, Massimiliano, et al.
Publicado: (2017)

Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
por: Zheng, Yadong, et al.
Publicado: (2023)

New Insights into the Molecular Bases of Familial Alzheimer’s Disease
por: D’Argenio, Valeria, et al.
Publicado: (2020)

The Potential Usefulness of the Expanded Carrier Screening to Identify Hereditary Genetic Diseases: A Case Report from Real-World Data
por: Veneruso, Iolanda, et al.
Publicado: (2023)

Gut bacteriome, mycobiome and virome alterations in rheumatoid arthritis
por: Dagar, Sonali, et al.
Publicado: (2023)

Evaluation of a Four-Gene Panel for Hereditary Cancer Risk Assessment
por: Secondino, Angela, et al.
Publicado: (2022)

Identification of a Killer Toxin from Wickerhamomyces anomalus with β-Glucanase Activity
por: Cecarini, Valentina, et al.
Publicado: (2019)

The TRPV1 ion channel regulates thymocyte differentiation by modulating autophagy and proteasome activity
por: Amantini, Consuelo, et al.
Publicado: (2017)

Gut microbiome and mycobiome in inflammatory bowel disease patients with Clostridioides difficile infection
por: Yu, Si, et al.
Publicado: (2023)

Enterotypes of the human gut mycobiome
por: Lai, Senying, et al.
Publicado: (2023)

Microbiome, Mycobiome and Related Metabolites Alterations in Patients with Metabolic Syndrome—A Pilot Study
por: Gradisteanu Pircalabioru, Gratiela, et al.
Publicado: (2022)

50 Hz Extremely Low Frequency Electromagnetic Fields Enhance Protein Carbonyl Groups Content in Cancer Cells: Effects on Proteasomal Systems
por: Eleuteri, A. M., et al.
Publicado: (2009)

Gut microbiome alterations in Alzheimer’s disease
por: Vogt, Nicholas M., et al.
Publicado: (2017)

The emerging role of the gut mycobiome in liver diseases
por: Szóstak, Natalia, et al.
Publicado: (2023)

Host Factors Associated with Gut Mycobiome Structure
por: Szóstak, Natalia, et al.
Publicado: (2023)

Activation of Non-Canonical Autophagic Pathway through Inhibition of Non-Integrin Laminin Receptor in Neuronal Cells
por: Limone, Adriana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o556bqvpde7e2cpjs05ok9ur85